These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28347399)

  • 1. Role of GALNT14 in lung metastasis of breast cancer.
    Kim MY
    BMB Rep; 2017 May; 50(5):233-234. PubMed ID: 28347399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
    Song KH; Park MS; Nandu TS; Gadad S; Kim SC; Kim MY
    Nat Commun; 2016 Dec; 7():13796. PubMed ID: 27982029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
    Wu J; Chen X; Bao Q; Duan R; Jin Y; Shui Y; Yao B; Lu X; Wang Y; Cui H; Li L; Yuan H; Ma C
    Cell Physiol Biochem; 2017; 44(3):998-1010. PubMed ID: 29227978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Kwon OS; Lee H; Kong HJ; Kwon EJ; Park JE; Lee W; Kang S; Kim M; Kim W; Cha HJ
    Oncogene; 2020 Jun; 39(23):4567-4580. PubMed ID: 32388539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
    Stern HM; Padilla M; Wagner K; Amler L; Ashkenazi A
    Clin Cancer Res; 2010 Mar; 16(5):1587-96. PubMed ID: 20179215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 May; 80():381-387. PubMed ID: 27133078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
    Wang R; Yu C; Zhao D; Wu M; Yang Z
    Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells.
    Chu YD; Fan TC; Lai MW; Yeh CT
    Cell Death Dis; 2022 Nov; 13(11):956. PubMed ID: 36376274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers.
    Lin WR; Yeh CT
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.
    Zuo T; Shan J; Liu Y; Xie R; Yu X; Wu C
    Transl Oncol; 2018 Apr; 11(2):346-352. PubMed ID: 29428518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
    Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
    Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Liang KH; Lin CL; Chen SF; Chiu CW; Yang PC; Chang ML; Lin CC; Sung KF; Yeh C; Hung CF; Chien RN; Yeh CT
    Pharmacogenomics; 2016 Mar; 17(4):353-66. PubMed ID: 26871639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
    Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer.
    Brooks SA; Carter TM; Bennett EP; Clausen H; Mandel U
    Acta Histochem; 2007; 109(4):273-84. PubMed ID: 17448526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen.
    Matsumoto Y; Zhang Q; Akita K; Nakada H; Hamamura K; Tokuda N; Tsuchida A; Matsubara T; Hori T; Okajima T; Furukawa K; Urano T; Furukawa K
    Biochem Biophys Res Commun; 2012 Mar; 419(1):7-13. PubMed ID: 22306014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
    Yeh CT; Liang KH; Lin CC; Chang ML; Hsu CL; Hung CF
    Int J Cancer; 2014 Mar; 134(5):1214-24. PubMed ID: 23959947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells.
    Shan J; Liu Y; Wang Y; Li Y; Yu X; Wu C
    Transl Oncol; 2018 Jun; 11(3):786-793. PubMed ID: 29702465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.